246 related articles for article (PubMed ID: 37261282)
1. Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis.
Xue T; Wu X; Li J; Chen S; Wang Z; Tan X; Wang Z; Zhang J
Front Pharmacol; 2023; 14():1175372. PubMed ID: 37261282
[No Abstract] [Full Text] [Related]
2. Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem.
Ufer M; Kelsh D; Schoedel KA; Dingemanse J
Sleep; 2022 Mar; 45(3):. PubMed ID: 34480579
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis.
Xue T; Wu X; Chen S; Yang Y; Yan Z; Song Z; Zhang W; Zhang J; Chen Z; Wang Z
Sleep Med Rev; 2022 Feb; 61():101573. PubMed ID: 34902823
[TBL] [Abstract][Full Text] [Related]
4. The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials.
Pan B; Ge L; Lai H; Hou L; Tian C; Wang Q; Yang K; Lu Y; Zhu H; Li M; Wang D; Li X; Zhang Y; Gao Y; Liu M; Ding G; Tian J; Yang K
Drugs; 2023 May; 83(7):587-619. PubMed ID: 36947394
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis.
McElroy H; O'Leary B; Adena M; Campbell R; Monfared AAT; Meier G
J Manag Care Spec Pharm; 2021 Sep; 27(9):1296-1308. PubMed ID: 34121443
[No Abstract] [Full Text] [Related]
6. Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial.
Fietze I; Bassetti CLA; Mayleben DW; Pain S; Seboek Kinter D; McCall WV
Drugs Aging; 2022 Oct; 39(10):795-810. PubMed ID: 36098936
[TBL] [Abstract][Full Text] [Related]
7. Dual orexin receptor antagonists for treatment of insomnia: A systematic review and meta-analysis on randomized, double-blind, placebo-controlled trials of suvorexant and lemborexant.
Khazaie H; Sadeghi M; Khazaie S; Hirshkowitz M; Sharafkhaneh A
Front Psychiatry; 2022; 13():1070522. PubMed ID: 36578296
[TBL] [Abstract][Full Text] [Related]
8. Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis.
Rocha RB; Bomtempo FF; Nager GB; Cenci GI; Telles JPM
Arq Neuropsiquiatr; 2023 May; 81(5):475-483. PubMed ID: 37257468
[TBL] [Abstract][Full Text] [Related]
9. Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis.
Na HJ; Jeon N; Staatz CE; Han N; Baek IH
Sleep; 2024 Feb; 47(2):. PubMed ID: 37950346
[TBL] [Abstract][Full Text] [Related]
10. Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
Murphy P; Moline M; Mayleben D; Rosenberg R; Zammit G; Pinner K; Dhadda S; Hong Q; Giorgi L; Satlin A
J Clin Sleep Med; 2017 Nov; 13(11):1289-1299. PubMed ID: 29065953
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.
De Crescenzo F; D'Alò GL; Ostinelli EG; Ciabattini M; Di Franco V; Watanabe N; Kurtulmus A; Tomlinson A; Mitrova Z; Foti F; Del Giovane C; Quested DJ; Cowen PJ; Barbui C; Amato L; Efthimiou O; Cipriani A
Lancet; 2022 Jul; 400(10347):170-184. PubMed ID: 35843245
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder.
Arnold V; Ancoli-Israel S; Dang-Vu TT; Mishima K; Pinner K; Malhotra M; Moline M
Neurol Ther; 2024 May; ():. PubMed ID: 38748321
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials.
Mignot E; Mayleben D; Fietze I; Leger D; Zammit G; Bassetti CLA; Pain S; Kinter DS; Roth T;
Lancet Neurol; 2022 Feb; 21(2):125-139. PubMed ID: 35065036
[TBL] [Abstract][Full Text] [Related]
14. Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder.
Chepke C; Jain R; Rosenberg R; Moline M; Yardley J; Pinner K; Kumar D; Perdomo C; Filippov G; Atkins N; Malhotra M
Postgrad Med; 2022 Apr; 134(3):316-325. PubMed ID: 35254948
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based insomnia treatment strategy using novel orexin antagonists: A review.
Kishi T; Nishida M; Koebis M; Taninaga T; Muramoto K; Kubota N; Moline M; Sakuma K; Okuya M; Nomura I; Iwata N
Neuropsychopharmacol Rep; 2021 Dec; 41(4):450-458. PubMed ID: 34553844
[TBL] [Abstract][Full Text] [Related]
16. Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis.
Kishi T; Nomura I; Matsuda Y; Sakuma K; Okuya M; Ikuta T; Iwata N
J Psychiatr Res; 2020 Sep; 128():68-74. PubMed ID: 32531478
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis.
Yue JL; Chang XW; Zheng JW; Shi L; Xiang YJ; Que JY; Yuan K; Deng JH; Teng T; Li YY; Sun W; Sun HQ; Vitiello MV; Tang XD; Zhou XY; Bao YP; Shi J; Lu L
Sleep Med Rev; 2023 Apr; 68():101746. PubMed ID: 36701954
[TBL] [Abstract][Full Text] [Related]
18. Daridorexant for the treatment of insomnia disorder: findings and implications.
Dos Santos JBR; da Silva MRR
Eur J Clin Pharmacol; 2022 Nov; 78(11):1749-1761. PubMed ID: 36098753
[TBL] [Abstract][Full Text] [Related]
19. Effect of the new dual orexin receptor antagonist daridorexant on nighttime respiratory function and sleep in patients with mild and moderate obstructive sleep apnea.
Boof ML; Dingemanse J; Lederer K; Fietze I; Ufer M
Sleep; 2021 Jun; 44(6):. PubMed ID: 33305817
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Sharpley AL
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
